Insider Trading activities at Pfenex Inc. (PFNX)

Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Pfenex Inc. (PFNX) since 2014 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Pfenex Inc.. Table 2 shows the detailed insider transactions. This company's CIK number is 1478121.

Total stock buying since 2014: $174,475.
Total stock sales since 2014: $99,760,316.
Total stock option exercises since 2014: $64,292.

Table 1. Yearly summary of insider stock purchases, sales, and option exercises at *Pfenex Inc.* (*PFNX*).
	Insider Buying		Insider Sales		Option Exercises
Year	Shares	Value	Shares	Value	Shares	Value
2020	0	$0	117,921	$1,474,181	17,921	$60,572
2019	0	$0	15,000	$138,170	0	$0
2018	26,000	$129,415	0	$0	0	$0
2017	10,000	$45,060	10,110	$86,633	2,000	$620
2016	0	$0	150,600	$1,441,421	6,000	$1,860
2015	0	$0	6,718,767	$96,383,775	4,000	$1,240
2014	0	$0	761,734	$236,136	0	$0

Table 2. Monthly summary of insider trading at *Pfenex Inc.* (*PFNX*).
Trading Period	Insider Buying		Insider Sales		Option Exercises
year-month	Shares	Value	Shares	Value	Shares	Value
2020-09	0	$0	100,000	$1,273,600	0	$0
2020-06	0	$0	770	$7,873	770	$2,602
2020-03	0	$0	17,151	$192,708	17,151	$57,970
2019-11	0	$0	3,000	$30,105	0	$0
2019-09	0	$0	12,000	$108,065	0	$0
2018-09	21,000	$105,140	0	$0	0	$0
2018-08	5,000	$24,275	0	$0	0	$0
2017-06	10,000	$45,060	0	$0	0	$0
2017-05	0	$0	2,000	$9,568	2,000	$620
2017-01	0	$0	8,110	$77,065	0	$0
2016-12	0	$0	139,600	$1,339,595	0	$0
2016-11	0	$0	7,000	$69,946	2,000	$620
2016-08	0	$0	2,000	$18,836	2,000	$620
2016-05	0	$0	2,000	$13,044	2,000	$620
2015-12	0	$0	608,500	$7,177,439	0	$0
2015-11	0	$0	8,500	$144,800	2,000	$620
2015-10	0	$0	1,500	$22,477	0	$0
2015-09	0	$0	8,500	$179,215	2,000	$620
2015-08	0	$0	6,500	$135,335	0	$0
2015-07	0	$0	6,500	$128,444	0	$0
2015-06	0	$0	6,500	$123,629	0	$0
2015-05	0	$0	6,500	$87,319	0	$0
2015-04	0	$0	6,054,267	$88,220,332	0	$0
2015-03	0	$0	11,500	$164,785	0	$0

Table 3. Detailed insider trading at *Pfenex Inc.* (*PFNX*)
Trade Date	Insider Name	Trade Type	Shares	Price ($)	Value ($)
2020-09-29	Wam Gp Llc (10% Owner)	Sale	100,000	12.74	1,273,600
2020-06-16	Lucy Patrick K. (Chief Business Officer)	Sale	770	10.22	7,873
2020-06-16	Lucy Patrick K. (Chief Business Officer)	Option Ex	770	3.38	2,602
2020-03-02	Lucy Patrick K. (Chief Business Officer)	Sale	17,151	11.24	192,708
2020-03-02	Lucy Patrick K. (Chief Business Officer)	Option Ex	17,151	3.38	57,970
2019-11-27	Lucy Patrick K. (Chief Business Officer)	Sale	3,000	10.04	30,105
2019-09-16	Lucy Patrick K. (Chief Business Officer)	Sale	2,050	10.01	20,510
2019-09-13	Lucy Patrick K. (Chief Business Officer)	Sale	3,950	10.01	39,531
2019-09-06	Lucy Patrick K. (Chief Business Officer)	Sale	6,000	8.00	48,024
2018-09-11	Schimmelpennink Evert B. (See Remarks)	Buy	10,000	5.03	50,250
2018-09-11	Schneider Phillip M (Director)	Buy	11,000	4.99	54,890
2018-08-22	Campbell Robin (Director)	Buy	5,000	4.86	24,275
2017-06-12	Grenfell-gardner Jason (Director)	Buy	10,000	4.51	45,060
2017-05-16	Lady Patricia (Chief Accounting Officer)	Sale	2,000	4.78	9,568
2017-05-16	Lady Patricia (Chief Accounting Officer)	Option Ex	2,000	.31	620
2017-01-06	Signet Healthcare Partners Accredited Partnership Iii Lp (10% Owner)	Sale	400	9.50	3,800
2017-01-05	Signet Healthcare Partners Accredited Partnership Iii Lp (10% Owner)	Sale	1,391	9.51	13,229
2017-01-04	Signet Healthcare Partners Accredited Partnership Iii Lp (10% Owner)	Sale	6,319	9.50	60,036
2016-12-29	Signet Healthcare Partners Accredited Partnership Iii Lp (10% Owner)	Sale	2,104	9.65	20,305
2016-12-28	Signet Healthcare Partners Accredited Partnership Iii Lp (10% Owner)	Sale	22,000	9.66	212,432
2016-12-27	Signet Healthcare Partners Accredited Partnership Iii Lp (10% Owner)	Sale	27,100	9.67	262,057
2016-12-23	Signet Healthcare Partners Accredited Partnership Iii Lp (10% Owner)	Sale	77,500	9.55	740,125
2016-12-22	Signet Healthcare Partners Accredited Partnership Iii Lp (10% Owner)	Sale	1,120	9.58	10,729
2016-12-21	Signet Healthcare Partners Accredited Partnership Iii Lp (10% Owner)	Sale	9,776	9.61	93,947
2016-11-21	Lady Patricia (Chief Accounting Officer)	Sale	2,000	9.87	19,736
2016-11-21	Lady Patricia (Chief Accounting Officer)	Option Ex	2,000	.31	620
2016-11-15	Lucy Patrick K. (Chief Business Officer)	Sale	5,000	10.04	50,210
2016-08-18	Lady Patricia (Chief Accounting Officer)	Sale	2,000	9.42	18,836
2016-08-18	Lady Patricia (Chief Accounting Officer)	Option Ex	2,000	.31	620
2016-05-24	Lady Patricia (Chief Accounting Officer)	Sale	2,000	6.52	13,044
2016-05-24	Lady Patricia (Chief Accounting Officer)	Option Ex	2,000	.31	620
2015-12-15	Dow Chemical Co /de/ (10% Owner)	Sale	600,000	11.75	7,050,000
2015-12-03	Lucy Patrick K. (Chief Business Officer)	Sale	1,500	14.15	21,231
2015-12-01	Talbot Henry W. Jr. (VP of Operations)	Sale	2,000	15.08	30,168
2015-12-01	Liang Bertrand C. (Chief Executive Officer)	Sale	5,000	15.21	76,040
2015-11-18	Lady Patricia (Chief Accounting Officer)	Sale	2,000	14.05	28,102
2015-11-18	Lady Patricia (Chief Accounting Officer)	Option Ex	2,000	.31	620
2015-11-04	Lucy Patrick K. (Chief Business Officer)	Sale	1,500	17.75	26,628
2015-11-02	Liang Bertrand C. (Chief Executive Officer)	Sale	5,000	18.01	90,070
2015-10-02	Lucy Patrick K. (Chief Business Officer)	Sale	1,500	14.98	22,477
2015-09-03	Lady Patricia (Chief Accounting Officer)	Sale	2,000	20.48	40,960
2015-09-03	Lady Patricia (Chief Accounting Officer)	Option Ex	2,000	.31	620
2015-09-03	Lucy Patrick K. (Chief Business Officer)	Sale	1,500	20.91	31,365
2015-09-01	Liang Bertrand C. (Chief Executive Officer)	Sale	5,000	21.38	106,890
2015-08-05	Lucy Patrick K. (Chief Business Officer)	Sale	1,500	20.75	31,125
2015-08-03	Liang Bertrand C. (Chief Executive Officer)	Sale	5,000	20.84	104,210
2015-07-06	Lucy Patrick K. (Chief Business Officer)	Sale	1,500	19.17	28,749
2015-07-01	Liang Bertrand C. (Chief Executive Officer)	Sale	5,000	19.94	99,695
2015-06-03	Lucy Patrick K. (Chief Business Officer)	Sale	1,500	20.08	30,119
2015-06-01	Liang Bertrand C. (Chief Executive Officer)	Sale	5,000	18.70	93,510
2015-05-04	Lucy Patrick K. (Chief Business Officer)	Sale	1,500	13.25	19,879
2015-05-01	Liang Bertrand C. (Chief Executive Officer)	Sale	5,000	13.49	67,440
2015-04-29	Signet Healthcare Partners Accredited Partnership Iii Lp	Sale	1,907,767	14.57	27,796,165
2015-04-29	Gale James C	Sale	1,907,767	14.57	27,796,165
2015-04-29	Dow Chemical Co /de/ (10% Owner)	Sale	2,232,233	14.57	32,523,634
2015-04-02	Lucy Patrick K. (Chief Business Officer)	Sale	1,500	17.62	26,428
2015-04-01	Liang Bertrand C. (Chief Executive Officer)	Sale	5,000	15.59	77,940
2015-03-04	Lucy Patrick K. (Chief Business Officer)	Sale	1,500	14.36	21,535
2015-03-02	Liang Bertrand C. (Chief Executive Officer)	Sale	10,000	14.32	143,250
2014-07-29	Signet Healthcare Partners Qp Partnership Ii Lp (10% Owner)	Sale	380,867	.31	118,068
2014-07-29	Gale James C (Director)	Sale	380,867	.31	118,068

Insider trading activities including stock purchases, stock sales, and option exercises of PFNX listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Pfenex Inc. (symbol PFNX, CIK number 1478121) see the Securities and Exchange Commission (SEC) website.

▪ Real-time Insider Trading

▪ Insider Officer Cluster Trading

▪ Top Officer Buys of the Week

▪ Top Officer Buys of the Month